News
Nearly every modern guideline (from the World Health Organization to the FDA) requires systematic reviews as the foundation ...
1d
Medpage Today on MSNGLP-1 Agonists Show Possible Benefits for Rare Blood Cancer
"Our studies have shown potential benefit of GLP-1 receptor agonists in polycythemia vera," he said. "Obviously, randomized ...
Abstract Purpose We conducted a randomized controlled trial (SURF-RCT) to evaluate the efficacy of surgery versus radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC). Simultaneously, ...
GLP-1a treatment in patients with polycythemia vera was linked to significant reductions in mortality, disease progression, and serious complications.
Real-world evidence on infection risks from multiple sclerosis treatments remains limited, with inconsistent findings ...
A new global systematic literature review and meta-analysis has shown that herpes zoster vaccination, used to prevent ...
Tumor necrosis factor inhibitor use in patients with IMIDs did not increase the risk of de novo heart failure or worsen existing heart failure.
9d
News-Medical.Net on MSNNew trial will test if a low-plastic lifestyle improves your health
A new protocol published in BMJ Open outlines the PERTH trial, a randomized controlled study testing whether a four-week ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results